Jiangsu Bioperfectus Technologies Co., Ltd.
Status: Publicly traded
Direct answer
Jiangsu Bioperfectus Technologies Co., Ltd. is publicly traded on SHH under the ticker 688399.SS.
Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
Can you invest in Jiangsu Bioperfectus Technologies Co., Ltd.?
Yes. Jiangsu Bioperfectus Technologies Co., Ltd. trades publicly on SHH as 688399.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu Bioperfectus Technologies Co., Ltd.
Detailed equity research is provided by MarketSnap.